VAERS reports by lot

Moderna COVID-19 lot 026620A: VAERS reports

35 VAERS reports list lot 026620A as a Moderna COVID-19 vaccine, received between 2020-12-29 and 2022-12-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
11%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological3623%
General / Systemic (non-local)3019%
Injection-site / Local reaction2717%
Gastrointestinal2013%
Cardiac / Cardiovascular138%
Musculoskeletal106%
Respiratory85%
Dermatological (non-injection-site)74%
Allergic / Anaphylactic32%
Psychiatric / Neuropsychiatric21%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey6
Pennsylvania3
Georgia3
Florida3
Connecticut2
Illinois2
Massachusetts2
Ohio2
New York2
South Carolina1
Rhode Island1
Indiana1

Reports by month received

2020-124
2021-0115
2021-024
2021-031
2021-042
2021-084
2021-112
2022-021
2022-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.